PT925065E - ERYTHROMYCIN COMPOSITIONS IN WATER - Google Patents

ERYTHROMYCIN COMPOSITIONS IN WATER

Info

Publication number
PT925065E
PT925065E PT97931511T PT97931511T PT925065E PT 925065 E PT925065 E PT 925065E PT 97931511 T PT97931511 T PT 97931511T PT 97931511 T PT97931511 T PT 97931511T PT 925065 E PT925065 E PT 925065E
Authority
PT
Portugal
Prior art keywords
water
erythromycin
water miscible
erythromycin compositions
compositions
Prior art date
Application number
PT97931511T
Other languages
Portuguese (pt)
Inventor
Raymond E Hopponen
Lowell R Macy
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of PT925065E publication Critical patent/PT925065E/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Jellies, Jams, And Syrups (AREA)

Abstract

Water miscible pharmaceutical compositions containing up to about 40% of erythromycin prepared by reaction with acetic acid in a non-aqueous water miscible organic solvent system.
PT97931511T 1996-07-02 1997-07-02 ERYTHROMYCIN COMPOSITIONS IN WATER PT925065E (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/675,380 US5723447A (en) 1996-07-02 1996-07-02 Water miscible erythromycin solutions

Publications (1)

Publication Number Publication Date
PT925065E true PT925065E (en) 2005-11-30

Family

ID=24710231

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97931511T PT925065E (en) 1996-07-02 1997-07-02 ERYTHROMYCIN COMPOSITIONS IN WATER

Country Status (13)

Country Link
US (1) US5723447A (en)
EP (1) EP0925065B1 (en)
JP (1) JP2000516205A (en)
AT (1) ATE304857T1 (en)
AU (1) AU717148B2 (en)
BR (1) BR9710118B1 (en)
CA (1) CA2259430C (en)
DE (1) DE69734242T2 (en)
DK (1) DK0925065T3 (en)
ES (1) ES2246515T3 (en)
NZ (1) NZ333574A (en)
PT (1) PT925065E (en)
WO (1) WO1998000146A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958888A (en) * 1996-07-02 1999-09-28 Merial, Inc. Water miscible macrolide solutions
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
US6780885B1 (en) * 2000-01-14 2004-08-24 Idexx Laboratories, Inc. Formulations and methods for administration of pharmacologically or biologically active compounds
US6914051B1 (en) * 2000-06-28 2005-07-05 David M Allen Penetrating antibiotic gel for soft tissue diseases
DE60114028T2 (en) 2000-08-23 2006-07-13 Wockhardt Ltd. METHOD FOR PRODUCING WATER-FREE AZITHROMYCIN
CN101785861B (en) 2001-10-19 2014-08-13 爱德士实验室公司 Injectable compositions for the controlled delivery of pharmacologically active compound
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
US20050049209A1 (en) * 2003-08-06 2005-03-03 Chen Andrew Xian Pharmaceutical compositions for delivering macrolides
US20050049210A1 (en) * 2003-08-27 2005-03-03 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
US7282487B2 (en) * 2004-10-28 2007-10-16 Idexx Laboratories Method for treating bacterial infections in horses or pigs with tilmicosin
ES2321639T3 (en) 2005-11-22 2009-06-09 Omrix Biopharmaceuticals S.A. APPLICATOR DEVICE FOR APPLYING A MULTICOMPONENT FLUID.
US7550625B2 (en) * 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU529422B2 (en) * 1978-10-20 1983-06-09 Eli Lilly And Company Stable erythromycin solution
US4264765A (en) * 1980-02-20 1981-04-28 Abbott Laboratories Salts of erythromycin A esters
US5175150A (en) * 1985-08-31 1992-12-29 Kitasato, Kenkyusho Erythromycin derivative
DE19518917A1 (en) * 1995-05-23 1996-11-28 Boehringer Ingelheim Vetmed Stable, concentrated, locally tolerated erythromycylamine solutions

Also Published As

Publication number Publication date
BR9710118B1 (en) 2010-02-23
ATE304857T1 (en) 2005-10-15
NZ333574A (en) 2000-03-27
AU717148B2 (en) 2000-03-16
ES2246515T3 (en) 2006-02-16
JP2000516205A (en) 2000-12-05
BR9710118A (en) 2000-01-18
WO1998000146A1 (en) 1998-01-08
CA2259430C (en) 2008-11-18
DE69734242T2 (en) 2006-01-26
AU3512497A (en) 1998-01-21
DK0925065T3 (en) 2005-10-17
EP0925065A4 (en) 2000-05-10
US5723447A (en) 1998-03-03
CA2259430A1 (en) 1998-01-08
DE69734242D1 (en) 2005-10-27
EP0925065B1 (en) 2005-09-21
EP0925065A1 (en) 1999-06-30

Similar Documents

Publication Publication Date Title
CA2336809A1 (en) Water miscible macrolide solutions
PT925065E (en) ERYTHROMYCIN COMPOSITIONS IN WATER
AR030045A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING ANTIBIOTIC COMPOUNDS OF AZALIDA, METHODS FOR OBTAINING
ES2118283T3 (en) DERIVATIVES OF ACIDS BENZOFURANIL- AND -TIOFENIL-ALCANOCARBOXILICOS.
MY129523A (en) 9. alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group
FR2707300B1 (en) Solid, transparent soap composition, based on fatty acid salts containing isoprene glycol.
ES2194679T3 (en) COSMETIC COMPOSITIONS CONTAINING CREATINE, CARNITINE AND / OR PYRUVIC ACID.
AU7448694A (en) Inclusion complex
ATE216228T1 (en) VALPROIC ACID CONTAINING MICROSPHERES FOR ORAL ADMINISTRATION
NO20030182L (en) Dermal application system for aminolevulinic acid
DK314289D0 (en) COMPOSITIONS
FI843264A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV ANTIMIKROBIELLA BENSOESYRADERIVAT.
EP0798383A3 (en) Method for preparing an ester compound using enzyme in non-Solvent Phase
ID16017A (en) PROCESS USED TO PRODUCE ORGANIC ACID
ES2174323T3 (en) NEW DERIVATIVES OF ERYTHROMYCIN, ITS PREPARATION PROCEDURE AND ITS APPLICATION AS MEDICATIONS.
DE69920039D1 (en) QUINAPRIL MAGNESIUM CONTAINING, PHARMACEUTIC EFFECTIVE COMPOSITION
DK55981A (en) PROCEDURE FOR THE PREPARATION OF 3'-BRAKE SUBSTITUTED DEACETOXYCEPHALOSPORANIC SULPHOXIDE DERIVATIVES
PT859795E (en) PROCESS FOR THE PREPARATION OF CRYSTALLINE IRON-DEXTRAN
WO1999024042A3 (en) Stable antiandrogenic gel composition
RU1807052C (en) 1,10-phenantrolinates of sodium or potassium 4-nitrophenyl-pyridinyl methanides having indicating properties to water or protonic organic solvents with interval of transition from blue to colorless at pk of 29
JPS5412369A (en) Preparation of thienylacetic acid
JPS5379856A (en) Preparation of optical active 1-methyl-2-(beta-hydroxyethyl)pyrrplidive
JPS53121785A (en) Preparation of 7-tetrazolylacetamidocephalosporanic acid derivatives
ITMI992761A0 (en) ENGINEERING ENVIRONMENT FOR THE FUNCTIONAL EDITING OF SYSTEM CONTROL STRATEGIES ACCORDING TO DIFFERENT LANGUAGES
TH15376A (en) Hydroximic acid derivatives